Moody’s takes negative outlook on AstraZeneca’s debt

July 28 (Reuters) – Moody’s Investors Service said on Fridayit changed its outlook on AstraZeneca Plc’s long-termdebt rating to negative from stable, a day after the company’sclosely watched advanced lung cancer trial failed.
The post Moody’s takes negative outlook on AstraZeneca’s debt appeared first on RocketNews | Top News Stories From Around the Globe.